“Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”. 2021. SKIN The Journal of Cutaneous Medicine 5 (1): s5. https://doi.org/10.25251/skin.5.supp.5.